Loading
PDBj
MenuPDBj@FacebookPDBj@TwitterPDBj@YouTubewwPDB FoundationwwPDB
RCSB PDBPDBeBMRBAdv. SearchSearch help

3SB5

Zn-mediated Trimer of T4 Lysozyme R125C/E128C by Synthetic Symmetrization

Summary for 3SB5
Entry DOI10.2210/pdb3sb5/pdb
Related3SB6 3SB7 3SB8 3SB9 3SBA 3SBB
DescriptorLysozyme, ZINC ION, CHLORIDE ION, ... (6 entities in total)
Functional Keywordsmetal-mediated synthetic symmetrization, synthetic symmetrization, hydrolase
Biological sourceEnterobacteria phage T4
Total number of polymer chains4
Total formula weight75910.77
Authors
Laganowsky, A.,Soriaga, A.B.,Zhao, M.,Sawaya, M.R.,Cascio, D.,Yeates, T.O. (deposition date: 2011-06-03, release date: 2011-09-21, Last modification date: 2024-02-28)
Primary citationLaganowsky, A.,Zhao, M.,Soriaga, A.B.,Sawaya, M.R.,Cascio, D.,Yeates, T.O.
An approach to crystallizing proteins by metal-mediated synthetic symmetrization.
Protein Sci., 20:1876-1890, 2011
Cited by
PubMed Abstract: Combining the concepts of synthetic symmetrization with the approach of engineering metal-binding sites, we have developed a new crystallization methodology termed metal-mediated synthetic symmetrization. In this method, pairs of histidine or cysteine mutations are introduced on the surface of target proteins, generating crystal lattice contacts or oligomeric assemblies upon coordination with metal. Metal-mediated synthetic symmetrization greatly expands the packing and oligomeric assembly possibilities of target proteins, thereby increasing the chances of growing diffraction-quality crystals. To demonstrate this method, we designed various T4 lysozyme (T4L) and maltose-binding protein (MBP) mutants and cocrystallized them with one of three metal ions: copper (Cu²⁺, nickel (Ni²⁺), or zinc (Zn²⁺). The approach resulted in 16 new crystal structures--eight for T4L and eight for MBP--displaying a variety of oligomeric assemblies and packing modes, representing in total 13 new and distinct crystal forms for these proteins. We discuss the potential utility of the method for crystallizing target proteins of unknown structure by engineering in pairs of histidine or cysteine residues. As an alternate strategy, we propose that the varied crystallization-prone forms of T4L or MBP engineered in this work could be used as crystallization chaperones, by fusing them genetically to target proteins of interest.
PubMed: 21898649
DOI: 10.1002/pro.727
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (2.46 Å)
Structure validation

227111

數據於2024-11-06公開中

PDB statisticsPDBj update infoContact PDBjnumon